Lonza - Lifescience-Konzern - Älteste Beiträge zuerst (Seite 6)
eröffnet am 27.09.17 13:06:37 von
neuester Beitrag 23.03.24 16:01:59 von
neuester Beitrag 23.03.24 16:01:59 von
Beiträge: 77
ID: 1.262.877
ID: 1.262.877
Aufrufe heute: 3
Gesamt: 10.588
Gesamt: 10.588
Aktive User: 0
ISIN: CH0013841017 · WKN: 928619
516,60
EUR
0,00 %
0,00 EUR
Letzter Kurs 07:57:04 Lang & Schwarz
Neuigkeiten
| Titel |
|---|
25.05.24 · wO Chartvergleich |
18.05.24 · wO Chartvergleich |
11.05.24 · wO Chartvergleich |
08.05.24 · wO Newsflash |
08.05.24 · wO Newsflash  |
Werte aus der Branche Chemie
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 0,6700 | +2.945,45 | |
| 2,0100 | +25,63 | |
| 13,410 | +16,51 | |
| 2,9400 | +12,64 | |
| 596,65 | +9,54 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 499,70 | -9,34 | |
| 28,15 | -9,43 | |
| 20,700 | -10,00 | |
| 6,3000 | -31,52 | |
| 7,6500 | -32,60 |
Feedback
Antwort auf Beitrag Nr.: 62.435.190 von pickuru am 21.01.20 08:57:28
Ja die Aktie sorgt immer für good News.. heisst oft für positive Überraschungen - das Long Invest vzahlz sich aus seit 2016.....ich mag Schweizer Aktien .....insbesondere in solchen Marktphasen wie dieser...
Oberkassel
Börse feiert die Zahlen von Lonza mit deutlichem Kursgewinn der Aktie
https://www.cash.ch/news/top-news/gesundheitsbranche-boerse-…Ja die Aktie sorgt immer für good News.. heisst oft für positive Überraschungen - das Long Invest vzahlz sich aus seit 2016.....ich mag Schweizer Aktien .....insbesondere in solchen Marktphasen wie dieser...
Oberkassel
bissel Gentherapie kommt hinzu:
Lonza übernimmt klinische Fertigung für Rocket Pharmaceuticals
https://www.finanzen.ch/nachrichten/aktien/lonza-uebernimmt-…
Lonza übernimmt klinische Fertigung für Rocket Pharmaceuticals
https://www.finanzen.ch/nachrichten/aktien/lonza-uebernimmt-…
1.5.
Moderna, Switzerland's Lonza strike deal on potential COVID-19 vaccine
https://finance.yahoo.com/news/moderna-switzerlands-lonza-st…
...
Moderna Inc and Swiss contract drugmaker Lonza Group AG said on Friday they would accelerate the manufacturing of the U.S. drug developer's potential coronavirus vaccine.
The announcement comes at a time when drugmakers are pausing clinical trials for other disease areas as they focus on testing potential treatments for the coronavirus.
The experimental vaccine, mRNA-1273, is being tested in early-stage trial by the U.S. National Institutes of Health, with Moderna expecting to begin mid-stage trial in the second quarter.
Under the 10-year collaboration agreement, the companies aim to manufacture up to a billion doses per year as technology transfer is expected to begin in June, and the first batches of the vaccine are expected to be manufactured in Lonza U.S. in July.
"Over time, the parties intend to establish additional production suites across Lonza's worldwide facilities, ultimately allowing for the manufacture of material equivalent to up to 1 billion doses of mRNA-1273 per year for use worldwide", the statement added.
The disease, which infected more than 3.2 million people worldwide and killed around 232,000, set off a race among drugmakers to find an antidote.
Earlier this month, Moderna got a $483 million funding from a U.S. government agency to accelerate its COVID-19 vaccine development.
Separately, Basel-based Lonza's pharmaceuticals, biotech and nutrition business has received more than 40 enquiries regarding projects relating to COVID-19, the company said earlier in April.
...
Moderna, Switzerland's Lonza strike deal on potential COVID-19 vaccine
https://finance.yahoo.com/news/moderna-switzerlands-lonza-st…
...
Moderna Inc and Swiss contract drugmaker Lonza Group AG said on Friday they would accelerate the manufacturing of the U.S. drug developer's potential coronavirus vaccine.
The announcement comes at a time when drugmakers are pausing clinical trials for other disease areas as they focus on testing potential treatments for the coronavirus.
The experimental vaccine, mRNA-1273, is being tested in early-stage trial by the U.S. National Institutes of Health, with Moderna expecting to begin mid-stage trial in the second quarter.
Under the 10-year collaboration agreement, the companies aim to manufacture up to a billion doses per year as technology transfer is expected to begin in June, and the first batches of the vaccine are expected to be manufactured in Lonza U.S. in July.
"Over time, the parties intend to establish additional production suites across Lonza's worldwide facilities, ultimately allowing for the manufacture of material equivalent to up to 1 billion doses of mRNA-1273 per year for use worldwide", the statement added.
The disease, which infected more than 3.2 million people worldwide and killed around 232,000, set off a race among drugmakers to find an antidote.
Earlier this month, Moderna got a $483 million funding from a U.S. government agency to accelerate its COVID-19 vaccine development.
Separately, Basel-based Lonza's pharmaceuticals, biotech and nutrition business has received more than 40 enquiries regarding projects relating to COVID-19, the company said earlier in April.
...
Trading Spotlight
Antwort auf Beitrag Nr.: 63.533.564 von faultcode am 01.05.20 20:56:12Lonza im Moderna-Hype:
Currency in CHF
https://finance.yahoo.com/quote/LONN.SW/?p=LONN.SW
Currency in CHF
https://finance.yahoo.com/quote/LONN.SW/?p=LONN.SW
LONZA KOOPERATIONSPARTNER MODERNA ERREICHT WEITEREN MEILENSTEIN
Die gute Nachricht von Moderna wird sicher auch Lonza weiter antreiben:https://www.deraktionaer.de/artikel/pharma-biotech/breaking-…
Auch wenn sich gelegentlich Skepsis breit macht - der angesehenste Virologe der neuen Welt setzt auf MODERNA. Und deshalb glaube ich, dass Lonza auch davon profitieren kann.
https://www.cnbc.com/2020/05/22/moderna-vaccine-researcher-i…
https://www.cnbc.com/2020/05/22/moderna-vaccine-researcher-i…
Pharma-Zulieferer Lonza will wachsen und den Gewinn steigern
https://de.reuters.com/article/schweiz-lonza-idDEKBN2700Q7Heute circa +3% für Lonza gegen den Markt. Top.
Oberkassel
DurchsuchenBeitrag zu dieser Diskussion schreiben
Investoren beobachten auch:
| Wertpapier | Perf. % |
|---|---|
| -0,17 | |
| +1,66 | |
| 0,00 | |
| +1,63 | |
| 0,00 | |
| +2,57 | |
| +1,64 | |
| 0,00 | |
| 0,00 | |
| 0,00 |
Meistdiskutiert
| Wertpapier | Beiträge | |
|---|---|---|
| 175 | ||
| 64 | ||
| 58 | ||
| 49 | ||
| 38 | ||
| 37 | ||
| 31 | ||
| 30 | ||
| 29 | ||
| 29 |
25.05.24 · wO Chartvergleich · ABB |
18.05.24 · wO Chartvergleich · Advanced Micro Devices |
11.05.24 · wO Chartvergleich · American Express |
08.05.24 · wO Newsflash · Lonza Group |
08.05.24 · EQS Group AG · Lonza Group |
27.04.24 · wO Chartvergleich · AT & S Austria Technologie & Systemtechnik |